Zhang YJ - Search Results

1

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.

Jin ZC, Chen JJ, Zhu XL, Duan XH, Xin YJ, Zhong BY, Chen JZ, Tie J, Zhu KS, Zhang L, Huang M, Piao MJ, Li X, Shi HB, Liu RB, Xu AB, Ji F, Wu JB, Shao GL, Li HL, Huang MS, Peng ZY, Ji JS, Yuan CW, Liu XF, Hu ZC, Yang WZ, Yin GW, Huang JH, Ge NJ, Qi X, Zhao Y, Zhou JW, Xu GH, Tu Q, Lin HL, Zhang YJ, Jiang H, Shao HB, Su YJ, Chen TS, Shi BQ, Zhou X, Zhao HT, Zhu HD, Ren ZG, Teng GJ; CHANCE2201 Investigators. Jin ZC, et al. Among authors: zhang l, zhang yj. EClinicalMedicine. 2024 May 6;72:102622. doi: 10.1016/j.eclinm.2024.102622. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38745965 Free PMC article.

2

Association of Sustained Response Duration With Survival After Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma.

Zhang Y, Zhang M, Chen M, Mei J, Xu L, Guo R, Lin X, Li J, Peng Z. Zhang Y, et al. JAMA Netw Open. 2018 Oct 5;1(6):e183213. doi: 10.1001/jamanetworkopen.2018.3213. JAMA Netw Open. 2018. PMID: 30646226 Free PMC article.

3

Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular Carcinoma.

Liu F, Chen M, Mei J, Xu L, Guo R, Lin X, Zhang Y, Peng Z. Liu F, et al. J Oncol. 2019 Sep 16;2019:6298502. doi: 10.1155/2019/6298502. eCollection 2019. J Oncol. 2019. PMID: 31636667 Free PMC article.

4

Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat?

Chen S, Peng Z, Zhang Y, Chen M, Li J, Guo R, Li J, Li B, Mei J, Feng S, Kuang M. Chen S, et al. Radiology. 2021 Mar;298(3):680-692. doi: 10.1148/radiol.2021202289. Epub 2021 Jan 19. Radiology. 2021. PMID: 33464183

5

Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis.

He MK, Peng C, Zhao Y, Liang RB, Lai ZC, Kan A, Li QJ, Wei W, Zhang YJ, Chen MS, Guo RP, Shi M. He MK, et al. Among authors: zhang yj. Cancer Immunol Immunother. 2021 Nov;70(11):3207-3216. doi: 10.1007/s00262-021-02911-w. Epub 2021 Apr 3. Cancer Immunol Immunother. 2021. PMID: 33813646 Free PMC article.

6

Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy versus lenvatinib alone for advanced hepatocellular carcinoma.

He MK, Liang RB, Zhao Y, Xu YJ, Chen HW, Zhou YM, Lai ZC, Xu L, Wei W, Zhang YJ, Chen MS, Guo RP, Li QJ, Shi M. He MK, et al. Among authors: zhang yj. Ther Adv Med Oncol. 2021 Mar 25;13:17588359211002720. doi: 10.1177/17588359211002720. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33854567 Free PMC article.

7

Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma.

Liang RB, Zhao Y, He MK, Wen DS, Bu XY, Huang YX, Lai ZC, Xu YJ, Kan A, Wei W, Zhang YJ, Chen MS, Guo RP, Li QJ, Shi M. Liang RB, et al. Among authors: zhang yj. Front Oncol. 2021 May 12;11:619461. doi: 10.3389/fonc.2021.619461. eCollection 2021. Front Oncol. 2021. PMID: 34055599 Free PMC article.

8

Long-term Outcomes of Transcatheter Arterial Chemoembolization Combined With Radiofrequency Ablation as an Initial Treatment for Early-Stage Hepatocellular Carcinoma.

Zhang YJ, Chen MS, Chen Y, Lau WY, Peng Z. Zhang YJ, et al. JAMA Netw Open. 2021 Sep 1;4(9):e2126992. doi: 10.1001/jamanetworkopen.2021.26992. JAMA Netw Open. 2021. PMID: 34570206 Free PMC article.

9

The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion.

Peng Z, Wu X, Li J, Pang H, Zhang Y, Lin M, Wang Z, Xiao H, Li B, Chen M, Feng S, Kuang M, Chen S. Peng Z, et al. Int J Hyperthermia. 2022;39(1):688-696. doi: 10.1080/02656736.2022.2051613. Int J Hyperthermia. 2022. PMID: 35469522 Free article.

10

Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy.

Wei MC, Zhang YJ, Chen MS, Chen Y, Lau WY, Peng ZW. Wei MC, et al. Among authors: zhang yj. Front Oncol. 2022 Jun 23;12:868429. doi: 10.3389/fonc.2022.868429. eCollection 2022. Front Oncol. 2022. PMID: 35814378 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,669 results

Search Page

Filters